Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012540) titled 'Statin, Ezetimibe, and Inclisiran for Plaque Regression in Acute Coronary Syndrome: A Randomized Controlled Trial (SEsiR-ACS Trial)' on Sept. 1.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Seoul National University Bundang Hospital
Condition:
Diseases of the circulatory system
Intervention:
Drug : The intervention in this study consists of pharmacological treatment and imaging-related evaluation procedures.
The intervention group receives early intensive lipid-lowering therapy during or as...